'Cipla has emerged as a great "catchment area" for talent'

An insider said that over the past decade or so Cipla has become immune to the exits of leaders. There have been no directional change in the long-term strategies. This is a pandemic-hit year, but......

Why GSK is changing its strategy after 93 years

Increased price control over branded generic medicines has affected its profitability GlaxoSmithKline (GSK) Pharmaceuticals is scouting for acquisitions in the domestic market for the first time......

Why price cap on drugs is counter productive

To ensure equal access to health care, the government must consider it in a holistic manner and improve all parameters, says Ranjit Shahani. India is the fourth fastest growing economy in......

Time for Indian pharma cos to change strategies

It's time for Indian generic companies to rethink their strategies, says Bhupesh Bhandari. In July, the European Commission imposed fines of euro 427.7 million on Servier of France and five......